Bottom line
How much do FHLC and HRTS overlap?
59% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 59.6% of FHLC's assets and 51.9% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.
FHLC holds far more positions (337 vs 45), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FHLC and HRTS have in common
| Holding | % of FHLC | % of HRTS | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.35% | 11.52% | 11.52% |
| Johnson & Johnson | 8.93% | 3.59% | 3.59% |
| AbbVie Inc | 6.42% | 2.40% | 2.40% |
| UnitedHealth Group Inc | 5.44% | 5.24% | 5.24% |
| Merck & Co Inc | 4.66% | 4.27% | 4.27% |
| Thermo Fisher Scientific Inc | 3.09% | 3.97% | 3.09% |
| Amgen Inc | 3.00% | 1.91% | 1.91% |
| Abbott Laboratories | 2.66% | 2.61% | 2.61% |
| Gilead Sciences Inc | 2.34% | 3.43% | 2.34% |
| Bristol-Myers Squibb Co | 1.93% | 2.09% | 1.93% |
| Danaher Corp | 1.80% | 2.66% | 1.80% |
| Vertex Pharmaceuticals Inc | 1.76% | 2.93% | 1.76% |
| Medtronic PLC | 1.59% | 1.88% | 1.59% |
| McKesson Corp | 1.52% | 1.71% | 1.52% |
| Regeneron Pharmaceuticals Inc | 1.15% | 1.67% | 1.15% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FHLC
- Pfizer Inc — 2.06%
- CVS Health Corp — 1.92%
- Intuitive Surgical Inc — 1.82%
- Stryker Corp — 1.62%
- Elevance Health Inc — 1.19%
- Cigna Group/The — 1.06%
- Boston Scientific Corp — 1.00%
- HCA Healthcare Inc — 0.91%
- Cencora Inc — 0.83%
- Cardinal Health Inc — 0.78%
Only in HRTS
- Novo Nordisk A/S — 5.24%
- Roche Holding AG — 4.50%
- AstraZeneca PLC — 4.00%
- Novartis AG — 3.38%
- Revolution Medicines Inc — 3.33%
- Bridgebio Pharma Inc — 2.59%
- Cytokinetics Inc — 2.52%
- Teva Pharmaceutical Industries — 2.06%
- Dexcom Inc — 1.92%
- Edwards Lifesciences Corp — 1.75%
Asset mix
| Asset type | FHLC | HRTS |
|---|---|---|
| Stocks | 99.7% | 99.2% |
| Cash & short-term funds | 0.2% | 0.7% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Country mix
| Country | FHLC | HRTS |
|---|---|---|
| US | 96.5% | 74.9% |
| CH | 0.1% | 7.9% |
| DK | — | 7.0% |
| GB | 0.5% | 4.0% |
| IE | 2.2% | 1.9% |
| IL | — | 2.1% |
| JP | — | 1.3% |
| CA | 0.2% | 0.9% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do FHLC and HRTS overlap?
What stocks do FHLC and HRTS have in common?
Should I own both FHLC and HRTS?
Which holds more stocks, FHLC or HRTS?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.